Marc Buffet
Overview
Explore the profile of Marc Buffet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nghiem-Buffet S, Fajnkuchen F, Buffet M, Ayrault S, Le Gloahec-Lorcy A, Grenet T, et al.
Ophthalmologica
. 2014 Nov;
232(4):216-22.
PMID: 25413000
Purpose: To investigate the outcome of intravitreal ranibizumab and/or dexamethasone implant treatment for treatment of macular edema (ME) secondary to central or branch retinal vein occlusion (CRVO or BRVO) in...
2.
Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, et al.
Transfusion
. 2013 May;
54(2):389-97.
PMID: 23711330
Background: Infectious events have been reported as major environmental triggers of thrombotic thrombocytopenic purpura (TTP). We detail here the potential association between infections and TTP. Study Design And Methods: We...
3.
Titah C, Abisror N, Affortit A, Buffet M, Coppo P
Graefes Arch Clin Exp Ophthalmol
. 2013 Mar;
252(1):181-3.
PMID: 23529795
No abstract available.
4.
Bachmeyer C, Buffet M, Moguelet P, Najman A, Aractingi S
Ann Hematol
. 2013 Mar;
92(10):1431-2.
PMID: 23455403
No abstract available.
5.
Ronchetti A, Isnard F, Buffet M, Coman T, Gorin N, Coppo P, et al.
Leuk Lymphoma
. 2012 Oct;
54(5):1117-9.
PMID: 23035656
No abstract available.
6.
Coppo P, Buffet M, Feger F, Lassoued K
Presse Med
. 2012 Jul;
42(3):327-37.
PMID: 22789311
Polyclonal CD8(+)/CD57(+)T cell lymphocytosis can be observed in various conditions such as chronic viral infections, autoimmune cytopenias, connective tissue diseases, chronic graft-versus-host disease and primary or secondary immune deficiencies. This...
7.
Benhamou Y, Assie C, Boelle P, Buffet M, Grillberger R, Malot S, et al.
Haematologica
. 2012 May;
97(8):1181-6.
PMID: 22580997
Background: Acquired thrombotic thrombocytopenic purpura is still associated with a 10-20% death rate. It has still not been possible to clearly identify early prognostic factors of death. This study involved...
8.
Beloncle F, Buffet M, Coindre J, Munoz-Bongrand N, Malot S, Pene F, et al.
Transfusion
. 2012 Mar;
52(11):2436-44.
PMID: 22404639
Background: The objective was to assess the efficacy and safety of splenectomy and cyclophosphamide as salvage therapies in severe thrombotic thrombocytopenic purpura (TTP). Study Design And Methods: During a 10-year...
9.
Froissart A, Buffet M, Veyradier A, Poullin P, Provot F, Malot S, et al.
Crit Care Med
. 2011 Sep;
40(1):104-11.
PMID: 21926591
Objective: To assess the efficacy and safety of rituximab in adults responding poorly to standard treatment for severe autoimmune thrombotic thrombocytopenic purpura. Design: Open-label prospective study. Outcomes in the survivors...
10.
Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, et al.
PLoS One
. 2010 May;
5(4):e10208.
PMID: 20436664
Severe ADAMTS13 deficiency occurs in 13% to 75% of thrombotic microangiopathies (TMA). In this context, the early identification of a severe, antibody-mediated, ADAMTS13 deficiency may allow to start targeted therapies...